Stockscreener 앱 받기
14.77
0.07%
-0.010
Immunic Inc 주식(IMUX)의 최신 뉴스
Why Did IMUX Stock Surge 33% Pre-Market Today? - Stocktwits
Immunic stock trades steadily as pipeline and Nasdaq listing shape investor focus - ad-hoc-news.de
Immunic announces participation in July investor conferences - Proactive financial news
Immunic to Participate in Investor Conferences in July - PR Newswire
Immunic Names CEO Erik Lundgren to Board - The Globe and Mail
Form 4 Immunic Inc For: 7 July By Investing.com - Investing.com Nigeria
Immunic director granted options for 25,370 shares | IMUX Insider Trading - Stock Titan
IMMUNIC (IMUX) director Barclay Phillips awarded 25,370 stock options as equity pay - Stock Titan
IMMUNIC (IMUX) director receives 25,370 stock options at $14.80 strike price - Stock Titan
Immunic (IMUX) director Jon Congleton granted 25,370 stock options at $14.80 - Stock Titan
Immunic Inc (IMUX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Immunic, Inc. Files Form 8-K Announcing Key Company Details and Executive Update (June 29, 2026) - Minichart
Immunic (IMUX) CEO Erik Lundgren appointed to Board as Tamar Howson retires - Stock Titan
Immunic, Inc. Announces Board and Committee Changes - marketscreener.com
IMUXImmunic Inc Options - Finviz
Form 4 Immunic Inc For: 29 June By Investing.com - Investing.com Australia
Immunic (IMUX) director Jon Congleton awarded 50,740 stock options at $10.90 - Stock Titan
Immunic (IMUX) director receives 25,370 fully vested options - Stock Titan
Immunic (IMUX) director receives grant of 25,370 fully vested options - Stock Titan
Immunic (NASDAQ: IMUX) director receives 25,370 stock options grant - Stock Titan
Immunic (IMUX) director Neermann receives fully vested options on 25,370 shares - Stock Titan
IMMUNIC (IMUX) director Barclay Phillips receives 25,370 fully vested stock options - Stock Titan
IMMUNIC (IMUX) President and COO receives 253,000-share stock option grant - Stock Titan
IMMUNIC (IMUX) CFO awarded stock options for 120,000 common shares - Stock Titan
IMMUNIC (IMUX) director receives 445,000 stock options at $11.60 exercise price - Stock Titan
[Form 4] IMMUNIC, INC. Insider Trading Activity - Stock Titan
Immunic (IMUX) investors boost equity pool and reelect directors at 2026 meeting - Stock Titan
Immunic, Inc.(NasdaqCM: IMUX) added to Russell Microcap Value Benchmark Index - marketscreener.com
Immunic, Inc.(NasdaqCM: IMUX) added to Russell 3000E Value Benchmark - marketscreener.com
Price to earnings forward of Immunic, Inc. – NASDAQ:IMUX - TradingView
Price to earnings forward of Immunic, Inc. – BOATS:IMUX - TradingView
Immunic tests Nurr1 to push beyond MS’s inflammation ceiling - biocentury.com
IMUX Stock Price, Quote & Chart - ChartMill
Enterprise value to revenue forward of Immunic, Inc. – MUN:10V - TradingView
Price to book forward of Immunic, Inc. – MUN:10V - TradingView
IMUX Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBITDA forward of Immunic, Inc. – NASDAQ:IMUX - TradingView
Immunic (IMUX) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Price to sales forward of Immunic, Inc. – NASDAQ:IMUX - TradingView
Enterprise value to EBIT forward of Immunic, Inc. – NASDAQ:IMUX - TradingView
Immunic Inc (FRA:10V) Stock Price & 30 Year Financial Data - GuruFocus
Eqs-News: Immunic to Present Additional Phase - Moomoo
Immunic consensus stays bullish, analysts back IMUX shares - AD HOC NEWS
Immunic Inc (IMUX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Immunic Inc (IMUX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Immunic Inc (IMUX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Immunic Inc (IMUX) Institutional Confidence - TradingKey
Immunic Inc (IMUX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer - mcduffieprogress.com
Immunic Inc (IMUX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Immunic Inc (IMUX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Immunic Inc (IMUX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Immunic Inc Stock (US45256V1061): Biotech share in focus after recent volatility - AD HOC NEWS
Immunic to showcase IMU-856 research at June conferences - Proactive financial news
2.64%
자본화:
|
볼륨(24시간):